Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from CSPC Pharmaceutical Group ( (HK:1093) ).
CSPC Pharmaceutical Group Limited announced the resignation of Mr. PAN Weidong as Executive Director and his replacement as the Authorized Representative by Dr. LI Chunlei. This change is part of the company’s ongoing management adjustments, which may influence its strategic direction and operational focus.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.
Average Trading Volume: 165,026,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$88.46B
Learn more about 1093 stock on TipRanks’ Stock Analysis page.